2023-08-10 12:20:26 ET
- Microcap Salarius Pharmaceuticals ( NASDAQ: SLRX ) is exploring strategic alternatives as it will also lay off more than 50% of employees.
- The company said those alternatives could include acquisition, merger, reverse merger, divestiture of assets, or licensing.
- It has retained Canaccord Genuity to examine potential alternatives.
- Salarius ( SLRX ) added that the company could also possibly wind-down operations.
- Seeking Alpha's Quant Rating views Salarius ( SLRX ) as a strong sell.
For further details see:
Salarius Pharmaceuticals exploring strategic alternatives; 50% workforce layoffs